메뉴 건너뛰기




Volumn 119, Issue 9, 2009, Pages 1304-1309

Duration of symptoms is not always the key modulator of the choice of reperfusion for ST-elevation myocardial infarction

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANISTREPLASE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RETEPLASE; STREPTOKINASE; UROKINASE;

EID: 63649094363     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.750679     Document Type: Review
Times cited : (5)

References (38)
  • 1
    • 0037417523 scopus 로고    scopus 로고
    • Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials
    • Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
    • (2003) Lancet , vol.361 , pp. 13-20
    • Keeley, E.C.1    Boura, J.A.2    Grines, C.L.3
  • 2
    • 13844275557 scopus 로고    scopus 로고
    • Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis
    • Nallamothu BK, Bates ER, Herrin J, Wang Y, Bradley EH. Krumholz HM. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation. 2005;111: 761-767.
    • (2005) Circulation , vol.111 , pp. 761-767
    • Nallamothu, B.K.1    Bates, E.R.2    Herrin, J.3    Wang, Y.4    Bradley, E.H.5    Krumholz, H.M.6
  • 3
    • 0141459347 scopus 로고    scopus 로고
    • Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: Is timing (almost) everything?
    • Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol. 2003;92:824-826.
    • (2003) Am J Cardiol , vol.92 , pp. 824-826
    • Nallamothu, B.K.1    Bates, E.R.2
  • 4
    • 4544304975 scopus 로고    scopus 로고
    • Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: Does the choice of fibrinolytic agent impact on the importance of time- to-treatment?
    • Nallamothu BK, Antman EM, Bates ER. Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time- to-treatment? Am J Cardiol. 2004;94:772-774.
    • (2004) Am J Cardiol , vol.94 , pp. 772-774
    • Nallamothu, B.K.1    Antman, E.M.2    Bates, E.R.3
  • 6
    • 28044439878 scopus 로고    scopus 로고
    • Explanation for the survival benefit of primary angioplasty over thrombolytic therapy in patients with ST-elevation acute myocardial infarction
    • Tarantini G, Razzolini R, Ramondo A, Napodano M, Bilato C, lliceto S. Explanation for the survival benefit of primary angioplasty over thrombolytic therapy in patients with ST-elevation acute myocardial infarction. Am J Cardiol. 2005;96:1503-1505.
    • (2005) Am J Cardiol , vol.96 , pp. 1503-1505
    • Tarantini, G.1    Razzolini, R.2    Ramondo, A.3    Napodano, M.4    Bilato, C.5    lliceto, S.6
  • 7
    • 0017643309 scopus 로고
    • The wavefront phenomenon of ischemic cell death, 1: Myocardial infarct size vs duration of coronary occlusion in dogs
    • Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death, 1: myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977;56:786-794.
    • (1977) Circulation , vol.56 , pp. 786-794
    • Reimer, K.A.1    Lowe, J.E.2    Rasmussen, M.M.3    Jennings, R.B.4
  • 8
    • 0030596903 scopus 로고    scopus 로고
    • Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour
    • Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348:771-775.
    • (1996) Lancet , vol.348 , pp. 771-775
    • Boersma, E.1    Maas, A.C.2    Deckers, J.W.3    Simoons, M.L.4
  • 9
    • 1642282903 scopus 로고    scopus 로고
    • Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: Every minute of delay counts
    • De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004; 109: 1223-1225.
    • (2004) Circulation , vol.109 , pp. 1223-1225
    • De Luca, G.1    Suryapranata, H.2    Ottervanger, J.P.3    Antman, E.M.4
  • 10
    • 0033529388 scopus 로고    scopus 로고
    • Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: Results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial
    • Berger PB, Ellis SG, Holmes DR Jr, Granger CB, Criger DA, Betriu A, Topol EJ, Califf RM. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation. 1999;100:14-20.
    • (1999) Circulation , vol.100 , pp. 14-20
    • Berger, P.B.1    Ellis, S.G.2    Holmes Jr, D.R.3    Granger, C.B.4    Criger, D.A.5    Betriu, A.6    Topol, E.J.7    Califf, R.M.8
  • 11
    • 30344461327 scopus 로고    scopus 로고
    • Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms
    • Brodie BR, Hansen C, Stuckey TD, Richter S. Versteeg DS, Gupta N, Downey WE, Pulsipher M. Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol. 2006;47:289-295.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 289-295
    • Brodie, B.R.1    Hansen, C.2    Stuckey, T.D.3    Richter, S.4    Versteeg, D.S.5    Gupta, N.6    Downey, W.E.7    Pulsipher, M.8
  • 13
    • 3843091541 scopus 로고    scopus 로고
    • Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110:588-636.
    • Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110:588-636.
  • 14
    • 3242760627 scopus 로고    scopus 로고
    • Aborted myocardial infarction in patients with ST-segment elevation: Insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy
    • Taher T, Fu Y, Wagner GS, Goodman SG, Fresco C, Granger CB, Wallentin L, van de Werf F, Verheugt F, Armstrong PW. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy. J Am Coll Cardiol. 2004;44:38-43.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 38-43
    • Taher, T.1    Fu, Y.2    Wagner, G.S.3    Goodman, S.G.4    Fresco, C.5    Granger, C.B.6    Wallentin, L.7    van de Werf, F.8    Verheugt, F.9    Armstrong, P.W.10
  • 15
    • 0345060917 scopus 로고    scopus 로고
    • Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: Data from the CAPTIM randomized clinical trial
    • Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2003;108:2851-2856.
    • (2003) Circulation , vol.108 , pp. 2851-2856
    • Steg, P.G.1    Bonnefoy, E.2    Chabaud, S.3    Lapostolle, F.4    Dubien, P.Y.5    Cristofini, P.6    Leizorovicz, A.7    Touboul, P.8
  • 17
    • 0028039957 scopus 로고
    • Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
    • Fibrinolytic Therapy Trialists, FTT Collaborative Group
    • Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311-322.
    • (1994) Lancet , vol.343 , pp. 311-322
  • 18
    • 33645027561 scopus 로고    scopus 로고
    • Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients
    • Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006;27:779-788.
    • (2006) Eur Heart J , vol.27 , pp. 779-788
    • Boersma, E.1
  • 19
    • 0023258694 scopus 로고
    • Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge
    • Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation. 1987;76:142-154.
    • (1987) Circulation , vol.76 , pp. 142-154
    • Chesebro, J.H.1    Knatterud, G.2    Roberts, R.3    Borer, J.4    Cohen, L.S.5    Dalen, J.6    Dodge, H.T.7    Francis, C.K.8    Hillis, D.9    Ludbrook, P.10
  • 20
    • 0032520991 scopus 로고    scopus 로고
    • PERM Study Group: Prospective Evaluation of Reperfusion Markers. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment
    • Steg PG, Laperche T, Golmard JL, Juliard JM, Benamer H, Himbert D, Aubry P; PERM Study Group: Prospective Evaluation of Reperfusion Markers. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. J Am Coll Cardiol. 1998;31:776-779.
    • (1998) J Am Coll Cardiol , vol.31 , pp. 776-779
    • Steg, P.G.1    Laperche, T.2    Golmard, J.L.3    Juliard, J.M.4    Benamer, H.5    Himbert, D.6    Aubry, P.7
  • 21
    • 0032959470 scopus 로고    scopus 로고
    • ALKK Study Group. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens
    • Zeymer U, Tebbe U, Essen R, Haarmann W, Neuhaus KL; ALKK Study Group. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. Am Heart J. 1999,137: 34-38.
    • (1999) Am Heart J , vol.137 , pp. 34-38
    • Zeymer, U.1    Tebbe, U.2    Essen, R.3    Haarmann, W.4    Neuhaus, K.L.5
  • 22
    • 0020661988 scopus 로고
    • Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis: Effect of molecular form and dose of activator, age of the thrombus, and route of administration
    • Collen D, Stassen JM, Verstraete M. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis: effect of molecular form and dose of activator, age of the thrombus, and route of administration. J Clin Invest. 1983;71:368-376.
    • (1983) J Clin Invest , vol.71 , pp. 368-376
    • Collen, D.1    Stassen, J.M.2    Verstraete, M.3
  • 23
    • 19244385186 scopus 로고    scopus 로고
    • Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis
    • Schomig A, Ndrepepa G, Mehilli J, Schwaiger M, Schuhlen H, Nekolla S, Pache J, Martinoff S, Bollwein H, Kastrati A. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation. 2003;108:1084-1088.
    • (2003) Circulation , vol.108 , pp. 1084-1088
    • Schomig, A.1    Ndrepepa, G.2    Mehilli, J.3    Schwaiger, M.4    Schuhlen, H.5    Nekolla, S.6    Pache, J.7    Martinoff, S.8    Bollwein, H.9    Kastrati, A.10
  • 25
    • 0027769607 scopus 로고
    • Reperfusion in acute myocardial infarction: Effect of timing and modulating factors in experimental models
    • Reimer KA, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol. 1993;72:13G-21G.
    • (1993) Am J Cardiol , vol.72
    • Reimer, K.A.1    Vander Heide, R.S.2    Richard, V.J.3
  • 26
    • 34548321324 scopus 로고    scopus 로고
    • Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging
    • Thiele H, Kappl MJ, Linke A, Erbs S, Boudriot E, Lembcke A, Kivelitz D, Schuler G. Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging. Eur Heart J. 2007;28:1433-1439.
    • (2007) Eur Heart J , vol.28 , pp. 1433-1439
    • Thiele, H.1    Kappl, M.J.2    Linke, A.3    Erbs, S.4    Boudriot, E.5    Lembcke, A.6    Kivelitz, D.7    Schuler, G.8
  • 27
    • 33749625211 scopus 로고    scopus 로고
    • Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction
    • Stenestrand U, Lindback J, Wallentin L. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA. 2006;296:1749-1756.
    • (2006) JAMA , vol.296 , pp. 1749-1756
    • Stenestrand, U.1    Lindback, J.2    Wallentin, L.3
  • 28
    • 0032080564 scopus 로고    scopus 로고
    • Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2)
    • Tiefenbrunn AJ, Chandra NC, French WJ, Gore JM, Rogers WJ. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 1998;31:1240-1245.
    • (1998) J Am Coll Cardiol , vol.31 , pp. 1240-1245
    • Tiefenbrunn, A.J.1    Chandra, N.C.2    French, W.J.3    Gore, J.M.4    Rogers, W.J.5
  • 29
    • 0037234960 scopus 로고    scopus 로고
    • Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: Final results of the randomized national multicentre trial-PRAGUE-2
    • Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, Branny M, St'asek J, Formanek P. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J. 2003;24:94-104.
    • (2003) Eur Heart J , vol.24 , pp. 94-104
    • Widimsky, P.1    Budesinsky, T.2    Vorac, D.3    Groch, L.4    Zelizko, M.5    Aschermann, M.6    Branny, M.7    St'asek, J.8    Formanek, P.9
  • 30
    • 0030908055 scopus 로고    scopus 로고
    • A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction
    • The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
    • The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336:1621-1628.
    • (1997) N Engl J Med , vol.336 , pp. 1621-1628
  • 33
    • 27644548513 scopus 로고    scopus 로고
    • Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial
    • Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, Collins R, Liu LS. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005; 366:1607-1621.
    • (2005) Lancet , vol.366 , pp. 1607-1621
    • Chen, Z.M.1    Jiang, L.X.2    Chen, Y.P.3    Xie, J.X.4    Pan, H.C.5    Peto, R.6    Collins, R.7    Liu, L.S.8
  • 34
    • 4644295398 scopus 로고    scopus 로고
    • The 2004 ACC/AHA Guidelines: A perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group
    • Armstrong PW, Bogaty P, Buller CE, Dorian P, O'Neill BJ. The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group. Can J Cardiol. 2004; 20:1075-1079.
    • (2004) Can J Cardiol , vol.20 , pp. 1075-1079
    • Armstrong, P.W.1    Bogaty, P.2    Buller, C.E.3    Dorian, P.4    O'Neill, B.J.5
  • 36
    • 0343035610 scopus 로고    scopus 로고
    • Zwolle Myocardial Infarction Study Group. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction
    • van't Hof AW, Liem A, de Boer MJ, Zijlstra F; Zwolle Myocardial Infarction Study Group. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet. 1997;350:615-619.
    • (1997) Lancet , vol.350 , pp. 615-619
    • van't Hof, A.W.1    Liem, A.2    de Boer, M.J.3    Zijlstra, F.4
  • 37
    • 0242552079 scopus 로고    scopus 로고
    • Clinical and angiographic correlates and outcomes of sub-optimal coronary flow in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
    • Mehta RH, Harjai KJ, Cox D, Stone GW, Brodie B, Boura J, O'Neill W, Grines CL. Clinical and angiographic correlates and outcomes of sub-optimal coronary flow in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2003;42:1739-1746.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1739-1746
    • Mehta, R.H.1    Harjai, K.J.2    Cox, D.3    Stone, G.W.4    Brodie, B.5    Boura, J.6    O'Neill, W.7    Grines, C.L.8
  • 38
    • 4444384496 scopus 로고    scopus 로고
    • Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction
    • Gibson CM, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004;44:980-987.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 980-987
    • Gibson, C.M.1    Murphy, S.A.2    Kirtane, A.J.3    Giugliano, R.P.4    Cannon, C.P.5    Antman, E.M.6    Braunwald, E.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.